As Southern Med Law Continues To Represent Men and Women In Product Liability Lawsuits, The Firm Reports Xarelto Lawsuit Claims The Blood Thinner May Cause Uncontrolled Bleeding Or Death As There Is No Antidote for Xarelto Bleeding.
The Xarelto attorneys at Southern Med Law note a Reuters report in which Germany-based Bayer Healthcare, the maker of Xarelto, has raised its forecast for Xarelto’s 2015 sales growth from 20 percent to 30 percent. While sales may be growing, the law firm has discovered that Bayer is also seeing a significant growth in the number of lawsuits being filed against the company, with over 600 complaints alleging severe bleeding side-effects and death as a result of using Xarelto. Court documents show that as of May 15, there are over 430 Xarelto complaints pending in the federal litigation established for Xarelto lawsuits in the U.S. District Court, Eastern District of Louisiana. There are nearly 240 cases pending, as of May 15, in a mass tort program established for Xarelto complaints in Pennsylvania’s Philadelphia Court of Common Pleas, according to court records. The Xarelto complaints all allege that Bayer and Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals, which markets the blood thinner, failed to warn doctors and their patients about Xarelto’s potential to cause significant bleeding events and left trauma professionals in hospital emergency rooms without an effective antidote to reverse the anticoagulant’s effects. (In Re: Xarelto Products Liability Litigation, MDL No. 2592)
[reuters.com/article/2015/04/30/bayer-results-xarelto-idUSL5N0XR49K20150430, April 30, 2015]
“Xarelto sales may be growing, but the defendants must face the allegations that their blood thinner medication caused severe injuries, and sometimes death, to the plaintiffs. Our law firm is committed to fighting for plaintiffs who suffered injuries from harmful drugs and other products because companies choose to put profits before people.” – Southern Med Law
The law firm is a dedicated leader in medical injury litigation and has successfully taken on some of the largest medical companies on behalf of its clients. Southern Med Law now offers free legal consultations to those who have suffered dangerous, uncontrolled bleeding allegedly due to the use of the blood thinner Xarelto. Call 1-205-547-5525 or fill out our online form located on the www.southernmedlaw.com website.
As stated in court records and the U.S. Food and Drug Administration (FDA), Xarelto was approved by the FDA to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation (abnormal heart rhythms) that is not caused by a heart valve problem. According to the FDA, Xarelto is considered a “next generation” blood thinner because it received FDA approval in recent years, compared to warfarin which was approved as a blood thinner in 1954 and is sold under the brand names, Coumadin and Jantoven. Court documents mention that even though warfarin requires patients to undergo regular blood monitoring, the anti-clotting medication has Vitamin K as an antidote should uncontrollable bleeding occur in the patient. Newer blood thinners, such as Xarelto, Eliquis and Pradaxa are marketed as being more convenient to use; however, they do not have a reversal agent to stop the severe bleeding, according to court records and the FDA.
[fda.gov/Drugs/NewsEvents/ucm405148.htm, July 17, 2014]
As stated in the Xarelto complaints, the defendants undertook an “intense marketing” campaign of Xarelto that resulted in large profits in the first three months of 2012, one year after Xarelto was approved by the FDA. The Xarelto lawsuits also state that the World Preview reported that Xarelto is estimated to be the “19th best-selling drug in the world by 2018,” with sales expected to jump from $596 million in 2012 to $3.7 billion in 2018. The Xarelto complaints contend that despite the predictions of enormous sales, the blockbuster drug continues to place patients at risk of severe bleeds and death. (In Re: Xarelto Products Liability Litigation, MDL No. 2592)
Legal Help For Victims Of Xarelto Bleeding Complications
Southern Med Law was founded by Dr. François Blaudeau, a physician and practicing attorney who has worked hard to develop a strong reputation in healthcare litigation. Dr. Blaudeau has made Southern Med Law an aggressive and effective advocate for those who have been harmed due to dangerous and defective drugs. If you or a loved one experienced life-threatening Xarelto bleeding complications, please contact the Firm today to learn more about your legal rights. You can arrange for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.